The past decade saw a significant increase in the preference for minimally invasive and over traditional surgical procedures. The variety of tools and techniques, skilled surgeons and technicians today make minimally invasive procedures easy. Furthermore, minimally invasive/nonsurgical alternatives offer advantages over traditional surgical procedures, such as less pain, reduced scarring, and quicker recovery. Government funds and reimburesemnet policies is also driving patients to opt for minimally invasive procedures.

The demand for microcatheter market in these countries is increasing owing to rapid growth in medical tourism, the growing adult (aged 20 and above) population, increasing cardiovascular and neurovascular diseases.

These countries are also home to a strong and qualified workforce and have a great knowledge of advance technologies.Furthermore, these countries have lenient policies for imports/exports and are underpenetrated in most aspects, which could help companies in brand development. Increasing developing technicians and the keen to know about new technologies is helping the regions to grow and update their technologies.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184715728 

Hospitals, Surgical centers & Specialty Clinics segment accounted for the largest share of the medical aesthetic, by end-user market in 2021.

The Hospitals, Surgical centers & Speciality Clinics segment dominates the market because most minimally invasive procedures are performed in hospitals, Surgical centers & Specialty. Increasing Cardiovascular and neurovascular procedures are taking place mainly in hospitals where trained surgeons perform the minimal invasive procedure with minute details and care.

North America  to register major growth in the market during the forecast period

North America microcatheter market is anticipated to register the highest growth over the forecast period of 2022 to 2027. North America accounted for the largest share of 46.4% of the microcatheters market in 2022. This market is projected to reach USD 1028 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. North America holds 46.4% share of the total microcatheter market. The large share of North America can be attributed to the high number of cardiovascular, neurovascular, and other target procedures performed in the region. Other factors such as large patient pool, the presence of a well-established healthcare system, and ongoing investments by hospitals to upgrade their operating rooms are also driving the growth of this regional segment.

As of 2022, prominent players in the microcatheter market are Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan).